drugset / Trial / NCT04394481

Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery

NCT04394481 ↗

Phase 4 Completed 122 enrolled Ramsay Santé Euraxi Pharma · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The main objective of the study is to demonstrate the efficacy of Dexmedetomidine on the prolongation of analgesia obtained by interscalenic bloc of the brachial plexus and intravenous injection of Dexamethasone (efficacy objective).

Timeline

Start
2020-09-28
Primary completion
2021-12-11
Completion
2021-12-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg Intravenous
Background Dexamethasone Small molecule 0.15 mg/kg Intravenous
Background Ropivacaine Other / unclassified 0.75 % Other
Background Ropivacaine Other / unclassified 20 ml Other

Indications